endo international plc
(ENDP:Consolidated Issue Listed on NASDAQ Global Select )
Carol A. Ammon M.B.A.
Founder, Endo International plc
|Age||Total Calculated Compensation||This person is connected to 56 board members in 2 different organizations across 3 different industries.|
See Board Relationships
Ms. Carol A. Ammon, MBA serves as the Chief Executive Officer of Endo Pharmaceuticals, Inc. Ms. Ammon founded Endo Pharmaceuticals Solutions Inc. She also founded and served as the Chairman and Chief Executive Officer of Endo Pharmaceuticals Holdings Inc., from February 2002 to May 20, 2005 and its President from February 2002 to April 2003. Prior to joining Endo in August 1997, Ms. Ammon served as the President of DuPont Mercks U.S. Pharmaceuticals Division from 1996 ...
Glandore Business CentresPhone: 353 1 699 4700
Dublin, Co. Dublin 2
Board Members Memberships*
Former Director, Chairman of Compensation Committee, Member of Corporate Governance Committee and Member of Strategic Planning Committee
Education*There is no Education data available.
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Timothy M. Ring||Chairman, Chief Executive Officer and Chairman of Executive Committee|
CR Bard Inc.
|Dow R. Wilson||Chief Executive Officer, President and Director|
Varian Medical Systems, Inc.
|Michael A. Mussallem||Chairman and Chief Executive Officer|
Edwards Lifesciences Corp.
|Gunupati Venkateswara Prasad B.Sc. (Chem. Eng.), M.S. (Indl. Admn.)||Co-Chairman, Managing Director, Chief Executive Officer, Member of The Management Council, Member of Management Committee, Member of Investment Committee, Member of Corporate Social Responsibility Committee and Member of Stakeholders' Relationship Committee|
Dr. Reddy's Laboratories Ltd.
|Mark Christopher Trudeau||Chief Executive Officer, President, Director and Member of Portfolio Committee|
Mallinckrodt public limited company
|$823.9K||Compensation as of Fiscal Year 2013.|